Cover Image
Market Research Report
Product code 
635924

Vascular Access Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Published: | Mordor Intelligence Pvt Ltd | 111 Pages | Delivery time: 2-3 business days

Price

Back to Top
Vascular Access Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Published: January 17, 2022
Mordor Intelligence Pvt Ltd
Content info: 111 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

The global vascular access devices market is expected to register a CAGR of nearly 6.5% during the forecast period. Over the past decade, there has been a rise in the prevalence of several chronic diseases that need vascular access treatment. Some of the major chronic diseases include cancer, kidney failure, and heart diseases, among others. Along with these, there are several lifestyle disorders relating to chronic and non-communicable disease conditions, such as hypertension, diabetes, obesity, and depression, among others, which need critical care during their hospitalization.

The prevalence of end-stage renal disease (ESRD), worldwide, is further increasing at a significant rate, resulting in chronic kidney disease (CKD). In 2017, in the United States, around 30 million people (15% of US adults) were found suffering from chronic kidney disease (CKD). CKD was found to be more common in women (16%) than in men (13%). For patients undergoing dialysis treatment, the ideal method of vascular access is through an arteriovenous fistula (ANF), by referring to a nephrologist about replacement therapy. The vascular access catheter devices are also significantly used in the case of chemotherapies.

According to the Center for Disease Control and Prevention (CDC), in the United States, nearly 0.65 million cancer patients receive chemotherapy in an outpatient oncology clinic annually. With the rising prevalence of chronic diseases and lifestyle disorders, the vascular access procedures are increasingly being used for intravenous antibiotic treatment, long intravenous nutritional support, and drawing of blood samples. Hence this is expected to draw the attention of several multinational medical devices companies to invest and launch new products, thus, acting as one of the major drivers for this market.

Key Market Trends

Administration of Drugs is Expected to Show a Large Share in the Application Segment

The drug administration segment is estimated to account for the largest share of the market as the growth of drug administration segment is attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases. Catheters are used for a variety of functions, including administering drugs, drawing blood, and specialized treatments like hemodialysis. Vascular access catheters can be inserted either peripherally in a patient's arm or centrally, such as in the patient's jugular.

North America to Dominate the Vascular Access Devices Market Over the Forecast Period

North America segment is expected to account for the largest share of the market that can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S.; an increase in the number of cancer cases; and an increase in research and clinical trials for vascular access devices.

Additionally, in a large number of cases of all the end-stage renal disease (ESRD), dialysis patients are treated via a catheter, which is performed in an outpatient setting, thus, reducing the hospitalization of ESRD patients by allowing the non-emergency interventional procedures to be carried out. The factors, such as government guidelines for the regulation of medical devices by the company, and better healthcare infrastructure, etc., play a key role in increasing the business and in the launching of new products by multinational companies, and thereby, contributing the market growth.

Competitive Landscape

The vascular access devices market is highly competitive and there are several small to mid-sized companies that are posing strong competition to gain the market share. However, few companies that are doing a good business in the market include B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, NIPRO Medical Corporation, and Fresenius Medical Care.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Product Code: 60445

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Lifestyle-related Disorders
    • 4.2.2 Increasing Number of Chemotherapy Procedures with High Hospitalization Rates
    • 4.2.3 Rising Use of Vascular Access Devices among Paediatric Patients
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Catheter Usage
    • 4.3.2 Stringent Regulations and Product Recalls
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Device Type
    • 5.1.1 Central Vascular Access Devices
      • 5.1.1.1 Peripherally Inserted Central Catheters
      • 5.1.1.2 Percutaneous Non-tunneled Catheters
      • 5.1.1.3 Other Central Vascular Access Devices
    • 5.1.2 Peripheral Vascular Access Devices
      • 5.1.2.1 Peripheral Catheter
      • 5.1.2.2 Midline Catheter
      • 5.1.2.3 Other Peripheral Vascular Access Devices
  • 5.2 By Application
    • 5.2.1 Administration of Drugs
    • 5.2.2 Administration of Fluid and Nutrition
    • 5.2.3 Diagnotics and Testing
    • 5.2.4 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospital/Clinic
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
    • 6.1.2 Baxter International Inc.
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Fresenius Medical Care AG & Co. KGaA
    • 6.1.5 Medtronic PLC
    • 6.1.6 Nipro Medical Corporation
    • 6.1.7 Siemens Healthineers
    • 6.1.8 Smiths Medical Inc.
    • 6.1.9 Teleflex Incorporated
    • 6.1.10 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS